BRCA1 and BRCA2 Mutations and Clinical Interpretation in 398 Ovarian Cancer Patients: Comparison With Breast Cancer Variants in a Similar Population

Human Genomics - United Kingdom
doi 10.1186/s40246-018-0171-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients From Brazil

Breast Cancer Research and Treatment
Cancer ResearchOncology
2006English

Hereditary Breast Cancer: Mutations Within BRCA1 and BRCA2 With Phenotypic Responses

2000English

Frequency of BRCA1 Mutations in B&H Breast and Ovarian Cancer Patients

Genetics & Applications
2018English

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy